267 related articles for article (PubMed ID: 12554376)
21. The release rate of curcumin from calcium alginate beads regulated by food emulsifiers.
Song S; Wang Z; Qian Y; Zhang L; Luo E
J Agric Food Chem; 2012 May; 60(17):4388-95. PubMed ID: 22497656
[TBL] [Abstract][Full Text] [Related]
22. Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide.
Barzegar-Jalali M; Hanaee J; Omidi Y; Ghanbarzadeh S; Ziaee S; Bairami-Atashgah R; Adibkia K
Drug Res (Stuttg); 2013 Feb; 63(2):60-4. PubMed ID: 23447074
[TBL] [Abstract][Full Text] [Related]
23. Development and evaluation of polyethyleneimine-treated calcium alginate beads for sustained release of diltiazem.
Halder A; Mukherjee S; Sa B
J Microencapsul; 2005 Feb; 22(1):67-80. PubMed ID: 16019892
[TBL] [Abstract][Full Text] [Related]
24. Cross-linked alginate-gelatine beads: a new matrix for controlled release of pindolol.
Ferreira Almeida P; Almeida AJ
J Control Release; 2004 Jul; 97(3):431-9. PubMed ID: 15212875
[TBL] [Abstract][Full Text] [Related]
25. External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation.
Quong D; Neufeld RJ; Skjåk-Braek G; Poncelet D
Biotechnol Bioeng; 1998 Feb; 57(4):438-46. PubMed ID: 10099220
[TBL] [Abstract][Full Text] [Related]
26. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro.
Downs EC; Robertson NE; Riss TL; Plunkett ML
J Cell Physiol; 1992 Aug; 152(2):422-9. PubMed ID: 1379248
[TBL] [Abstract][Full Text] [Related]
27. Controlled release tamsulosin hydrochloride from alginate beads with waxy materials.
Kim MS; Park GD; Jun SW; Lee S; Park JS; Hwang SJ
J Pharm Pharmacol; 2005 Dec; 57(12):1521-8. PubMed ID: 16354396
[TBL] [Abstract][Full Text] [Related]
28. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique.
Wells LA; Sheardown H
Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984
[TBL] [Abstract][Full Text] [Related]
29. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
Vostalová L; Rabisková M; Medvecká G
Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
[TBL] [Abstract][Full Text] [Related]
30. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
Abd-Elbary A; Haider M; Sayed S
Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
[TBL] [Abstract][Full Text] [Related]
31. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
32. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads.
Pasparakis G; Bouropoulos N
Int J Pharm; 2006 Oct; 323(1-2):34-42. PubMed ID: 16828245
[TBL] [Abstract][Full Text] [Related]
33. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
Fan TY; Wei SL; Yan WW; Ding WX
Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
[TBL] [Abstract][Full Text] [Related]
34. Xanthan-alginate composite gel beads: molecular interaction and in vitro characterization.
Pongjanyakul T; Puttipipatkhachorn S
Int J Pharm; 2007 Feb; 331(1):61-71. PubMed ID: 17046185
[TBL] [Abstract][Full Text] [Related]
35. Alginate-coated alginate-polyethyleneimine beads for prolonged release of furosemide in simulated intestinal fluid.
Setty CM; Sahoo SS; Sa B
Drug Dev Ind Pharm; 2005 May; 31(4-5):435-46. PubMed ID: 16093209
[TBL] [Abstract][Full Text] [Related]
36. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
Bendas ER
Arch Pharm Res; 2009 Sep; 32(9):1317-29. PubMed ID: 19784589
[TBL] [Abstract][Full Text] [Related]
37. Floating dosage forms to prolong gastro-retention--the characterisation of calcium alginate beads.
Stops F; Fell JT; Collett JH; Martini LG
Int J Pharm; 2008 Feb; 350(1-2):301-11. PubMed ID: 17964096
[TBL] [Abstract][Full Text] [Related]
38. Aging and microwave effects on alginate/chitosan matrices.
Wong TW; Chan LW; Kho SB; Heng PW
J Control Release; 2005 Jun; 104(3):461-75. PubMed ID: 15911046
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluation of a novel diltiazem hydrochloride polydispersity sustained-release system.
Sun C; Liu H; Zhao X; He H; Pan W
Drug Dev Ind Pharm; 2013 Jan; 39(1):62-6. PubMed ID: 22339081
[TBL] [Abstract][Full Text] [Related]
40. Investigation of coated whey protein/alginate beads as sustained release dosage form in simulated gastrointestinal environment.
Hébrard G; Hoffart V; Cardot JM; Subirade M; Alric M; Beyssac E
Drug Dev Ind Pharm; 2009 Sep; 35(9):1103-12. PubMed ID: 19365776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
